BLT 0.00% 2.6¢ benitec biopharma limited

RNAi for Neuro Degen Diseases

  1. 2,326 Posts.
    lightbulb Created with Sketch. 12
    yet another study (mouse) showing ddRNAi to be a very promising prospect for
    one day treating neuro type degenerative diseases (this one SCA3).

    http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100086

    Beverly Davidson's group seem most advanced in this area as they have managed
    to get Rhesus monkeys with Huntingtons up and performing pretty much as good
    as normal monkeys. They are using artificial mirna scaffold construct to get a better
    result.

    we've seen plenty on other related neuro diseases where ddRNAi is looking the goods.

    sure it could still be a way off before these prospects get into real patients, but i
    sure want to be on the company best positioned to do this. Whether Benitec is
    to be that company remains to be seen.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.